Hepatitis Clinical Trials in Los Angeles

Showing 241-241 of 241 trials

A Safety Study to Evaluate 12 Weeks of Treatment with Clevudine in Patients Infected with Hepatitis B Virus.

NCT00044135

The purpose of the study is to evaluate the safety and effectiveness of 12 weeks of treatment with clevudine, at one of three doses, in patients chronically infected with hepatitis B virus.

Hepatitis B

Triangle Pharmaceuticals30 participantsStarted Aug 2002

Chicago, Illinois, United States • Philadelphia, Pennsylvania, United States • Vancouver, Canada +8 more locations

PreviousPage 13 of 13

A Safety Study to Evaluate 12 Weeks of Treatment with Clevudine in Patients Infected with Hepatitis B Virus.

Hepatitis Trials in Other Cities

Other Conditions in Los Angeles